Abstract

Localized Management of Soft Tissue Sarcoma Metastasis: A Review of a Multidisciplinary Approach.

Highlights

  • Soft tissue sarcomas (STS) are a rare malignancy that has unpredictable clinical and pathologic behaviors

  • Canter et al, showed that the median post-metastasis disease-specific survival rates in patients with pulmonary-only metastases were lower for those that were administered chemotherapy compared to those that were treated with surgery alone, 24 vs 33 months [25]

  • Studies have demonstrated that patients with limited burden pulmonary disease (≤5 pulmonary metastases) have higher median metastatic survival of up to 55 months [7]

Read more

Summary

Introduction

Soft tissue sarcomas (STS) are a rare malignancy that has unpredictable clinical and pathologic behaviors. Despite excellent rates of local control with surgery, radiation and chemotherapy, metastasis develops in approximately 25-30% of patients [1,2,3,4,5]. STS metastasis most commonly spreads to the lungs, other areas of distant disease, such as soft tissue, bone, and visceral organs have been identified [6]. The metastatic potential for primary STS may be a result of various factors, and identifying these factors that influence metastatic survival is crucial if sarcoma specialists are to be able to discuss treatment options and prognosis with their patients. The mainstay of therapy for disseminated metastatic STS is chemotherapy. There has been an evolution in this patient population toward the utilization of less invasive treatment modalities such as radiation and percutaneous ablative techniques to treat metastatic lesions [8,9,10,11,12]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.